Modelling of glucose-insulin dynamics from low sampled data

Abstract In this paper we focus on modelling the glucose-insulin dynamics in the human body for the purpose of controlling the glucose level. Due to the fast dynamics in the glucose-insulin system compared to the natural sampling period (24 h) in a clinical situation, the model structure has to be adapted adequately. This results in a reduced order model with a nonlinear output relation. The development of the estimation methodology is based on a simulation study with a continuous time model. The resulting model structure is used for estimating the parameters of the non-linear system, representing the slow dynamics observed from the slow and sparse sampled clinical data.

[1]  Ian Postlethwaite,et al.  Multivariable Feedback Control: Analysis and Design , 1996 .

[2]  Y. Z. Ider,et al.  Quantitative estimation of insulin sensitivity. , 1979, The American journal of physiology.

[3]  C Cobelli,et al.  Quantitative Estimation of Beta Cell Sensitivity to Glucose in the Intact Organism: A Minimal Model of Insulin Kinetics in the Dog , 1980, Diabetes.

[4]  P. Hogan,et al.  Economic Costs of Diabetes in the U , 2013 .

[5]  S. Ingwersen,et al.  Modeling of 24‐hour glucose and insulin profiles in patients with type 2 diabetes mellitus treated with biphasic insulin aspart , 2014, Journal of clinical pharmacology.

[6]  T. Heise,et al.  Insulin degludec: Lower day‐to‐day and within‐day variability in pharmacodynamic response compared with insulin glargine 300 U/mL in type 1 diabetes , 2017, Diabetes, obesity & metabolism.

[7]  N. Wong,et al.  Comparison of demographic factors and cardiovascular risk factor control among U.S. adults with type 2 diabetes by insulin treatment classification. , 2012, Journal of diabetes and its complications.

[8]  Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013;36:1033–1046 , 2013, Diabetes Care.

[9]  B. Zinman,et al.  Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes , 2012, Diabetes Care.

[10]  Y. Jang,et al.  Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .

[11]  Henrik Bengtsson,et al.  Model for Simulating Fasting Glucose in Type 2 Diabetes and the Effect of Adherence to Treatment. , 2017 .

[12]  Garry M. Steil,et al.  Identification of Intraday Metabolic Profiles during Closed-Loop Glucose Control in Individuals with Type 1 Diabetes , 2009, Journal of diabetes science and technology.

[13]  Plamen Nikolov,et al.  Economic Costs of Diabetes in the U.S. in 2002 , 2003, Diabetes care.

[14]  R. Hovorka,et al.  Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. , 2004, Physiological measurement.

[15]  Claudio Cobelli,et al.  Meal Simulation Model of the Glucose-Insulin System , 2007, IEEE Transactions on Biomedical Engineering.

[16]  Roman Hovorka,et al.  Modelling endogenous insulin concentration in type 2 diabetes during closed-loop insulin delivery , 2015, BioMedical Engineering OnLine.

[17]  Mats O Karlsson,et al.  Modeling of 24‐Hour Glucose and Insulin Profiles of Patients With Type 2 Diabetes , 2011, Journal of clinical pharmacology.